Introduction {#s1}
============

Headache is the fundamental symptom for a diagnosis of acute mountain sickness (AMS) according to the Lake Louise Scoring System (Imray et al., [@B21]; Bartsch and Swenson, [@B3]; Davis and Hackett, [@B12]). In this context, high-altitude headache (HAH) is a defined and recognized headache disorder, which occurs within 24 h after ascending to an altitude of \>2,500 m, based on the International Classification of Headache Disorders 3β criteria (Marmura and Hernandez, [@B33]; Kim et al., [@B24]). Approximately 80% of people are thought to experience headache after rapidly ascending to high altitudes, which is associated with disturbances in their daily life and work that create an important public health problem (Carod-Artal, [@B9]).

During recent decades, numerous researchers have systematically investigated the epidemiology, clinical manifestations, pathophysiological mechanisms, risk factors, prevention, and treatment of HAH (Wilson et al., [@B43]; Carod-Artal, [@B9]; Marmura and Hernandez, [@B33]). Clinical studies have demonstrated that HAH ordinarily presents as a sudden attack and partially mimics the features of migraine (Silber et al., [@B40]; Broessner et al., [@B7]). Current studies regarding the pathophysiological etiology of HAH have suggested that HAH can be induced by hypobaric hypoxia causing overperfusion of the microvascular beds, brain swelling, activation of the trigeminal vascular system, and sensitization of intracranial pain receptors (Burtscher et al., [@B8]). Furthermore, the known independent risk factors for HAH include increased heart rate (HR), posterior cerebral circulation, vertebral artery diastolic velocity, and anxiety; decreased pulse oxygen saturation (SpO~2~) and vigor; and a history of migraine or microRNA dysregulation (Silber et al., [@B40]; Lawley, [@B25]; Alizadeh et al., [@B1]; Bian et al., [@B5], [@B4]; Liu et al., [@B29]; Dong et al., [@B14]; Guo et al., [@B16]). However, the actual underlying mechanisms, clinical manifestations and risk factors/predictors remain not entirely clear, despite accumulating evidence regarding HAH (Marmura and Hernandez, [@B33]).

Hematological parameters are important clinical markers and can be analyzed using simple, rapid, and inexpensive techniques (Devasena, [@B13]). Numerous researchers have suggested that hematological changes are closely associated with various diseases, including myelodysplastic syndrome, laryngeal squamous cell cancer, stable coronary artery disease, stroke, and acute pulmonary embolism (Nayak et al., [@B34]; List et al., [@B27]; Zorlu et al., [@B45]; Ayhan et al., [@B2]; Sahin et al., [@B38]; Soderholm et al., [@B41]; Hsueh et al., [@B20]). Moreover, recent studies have indicated that migraine conditions may be related to some hematological parameters, especially high hemoglobin levels and broad red blood cell distribution width (Celikbilek et al., [@B10]; Lippi et al., [@B26]). Thus, hematological changes are an attractive area for improving our understanding of HAH, although we are not aware of any studies that have examined this issue.

The present study was based on the hypothesis that hematological parameters would be closely related to HAH. Therefore, we evaluated the hematological characteristics of participants before and after exposure to high altitude, which may provide useful information regarding HAH-specific hematological phenotypes, independent risk factors, and predictors.

Methods {#s2}
=======

Participants
------------

The inclusion criteria were healthy 18--60-year-old Chinese men whose primary residence was at an altitude of ≤1,000 m. The exclusion criteria were cardio-cerebrovascular diseases, respiratory diseases, neuropsychological diseases, kidney disorders, liver disorders, migraine or other headaches, history of travel to an altitude of \>2,500 m during the last 2 years, and regularly drinking coffee or tea. Based on these criteria, we successfully recruited and enrolled 45 Chinese men who were healthy and 18--35 years old. The study\'s protocol was approved by the Third Military Medical University Ethics Committee (China), and complied with the requirements of the Declaration of Helsinki. All participants signed informed consent forms before their enrollment.

Procedures
----------

During the study, all participants rapidly ascended from Chongqing (sea level, altitude of 200 m) to Lhasa (altitude of 3,700 m) by train within 48 h. Three days before the ascent, the participants provided demographic data and underwent measurements of physiological and hematological parameters at sea level. Within 24 h after their arrival at 3,700 m, the participants underwent assessments of their physiological and hematological parameters, as well as HAH. During the study, the participants maintained the same diet (no coffee, tea, or alcoholic drinks) and avoided strenuous activity to ensure a similar level of physical activity. The participants were monitored by physicians for any signs of high-altitude cerebral or pulmonary edema (Hackett and Roach, [@B17]; Pennardt, [@B37]). The possibility of emergent cases of these conditions was addressed by planning for immediate evacuation and treatment using oxygen supplementation and medication.

Demographic and clinical data collection
----------------------------------------

Three days before their ascent, the participants completed self-administered questionnaires to obtain their demographic data (body mass index \[BMI\], age, smoking history, and drinking history). After the acute exposure at 3,700 m, the physicians scored the participants based on the clinical features of HAH: headache (0 = none, 1 = mild, 2 = moderate, 3 = severe), the location of the headache (bilateral, frontal, frontal-temporal, or other), and factors that worsened the headache (exertion, movement, straining, coughing, or other). The diagnosis of HAH was based on fulfilling at least two of the International Classification of Headache Disorders 3β criteria (Marmura and Hernandez, [@B33]): mild or moderate severity; bilateral location; and aggravation caused by exertion, movement, straining, coughing, and/or bending.

Measurement of physiological parameters
---------------------------------------

During the pre-exposure and post-exposure examinations, physicians measured the participants\' physiological parameters, including HR, SpO~2~, diastolic blood pressure (DBP), and systolic blood pressure (SBP). The participants rested for 30 min before being evaluated using a sphygmomanometer (HEM-6200; OMRON, China) and a pulse oximeter (NONIN-9550; Nonin Onyx, USA).

Blood collection and hematological parameter measurements
---------------------------------------------------------

Pre-exposure and post-exposure venous blood samples were collected from the participants by qualified nurses using EDTA-coated tubes and standard procedures. The blood samples were stored at 4°C until the testing using the AU-2700 analyzers (Olympus, Tokyo, Japan) and commercial reagents. The hematological parameters were white blood cell count (WBC), red blood cell count (RBC), hematocrit (HCT), mean corpuscular volume, red cell distribution width and its coefficient of variation, platelet count, mean platelet volume, plateletcrit, platelet distribution width, platelet-large cell ratio, hemoglobin (HGB), mean corpuscular hemoglobin and concentration, neutrophil count (NEU\#), reticulocyte count (RET\#), lymphocyte count (LYM\#), eosinophil count (EOS\#), monocyte count (MON\#), neutrophil percentage (NEU%), reticulocyte percentage (RET%), lymphocyte percentage (LYM%), eosinophil percentage (EOS%), and monocyte percentage (MON%) (Supplementary Table [1](#SM1){ref-type="supplementary-material"}).

Statistical analysis
--------------------

The parameters\' normality was assessed using the Shapiro-Wilk\'s test. Normally distributed data were presented as mean ± standard deviation, non-normally distributed data were presented as median (interquartile range), and categorical data were presented as number (percentage). Differences between the groups with and without HAH (HAH+/HAH−) were compared using the independent *t*-test for normally distributed data and the Mann-Whitney *U*-test for non-normally distributed data. Spearman correlation coefficients were evaluated for the relationships between the parameters and HAH severity scores. Univariate logistic regression was used to identify risk factors and predictors, and significant factors from the aforementioned analyses were included in adjusted logistic regression (Figure [1](#F1){ref-type="fig"}). All analyses were performed using IBM SPSS software (version 19; IBM Corp, Armonk, NY, USA), and differences were considered statistically significant at a *P*-value of \< 0.05. All statistical methods and results were discussed with and guided by statisticians from the Third Military Medical University.

![The flow diagram of this study. HAH+, participants with high-altitude headache (HAH); HAH−, participants without HAH.](fphys-08-00801-g0001){#F1}

Results {#s3}
=======

Demographic and clinical characteristics
----------------------------------------

All 45 participants completed the pre-exposure and post-exposure assessments, and had complete data regarding their physiological and hematological parameters. The incidence of HAH was 51.1%, although no significant differences were observed between the HAH+ and HAH− groups for age, BMI, drinking, and smoking (all *P* \> 0.05, Table [1](#T1){ref-type="table"}).

###### 

Differences of each variable between HAH+ and HAH− groups.

                                                   **Measurements at sea level**   **Measurements at 3,700 m**                                                     
  ------------------------------------------------ ------------------------------- ------------------------------------------------------- ----------------------- ---------------------------------------------------------
  **DEMOGRAPHIC DATA**                                                                                                                                             
  Age (year)                                       26.1 (3.0)                      24.4 (9.0)                                              The same as sea level   
  BMI (kg/m^2^)                                    20.8 (3.0)                      22.2 (1.5)                                              The same as sea level   
  Smoking                                          2 (8.70%)                       3 (13.6%)                                               The same as sea level   
  Drinking                                         7 (30.4%)                       5 (22.7%)                                               The same as sea level   
  **PHYSIOLOGICAL PARAMETERS**                                                                                                                                     
  SBP (mmHg)                                       110.6 ± 8.2                     110.1 ± 6.7                                             122.6 ± 13.7            123.3 ± 10.8
  DBP (mmHg)                                       67.0 ± 7.4                      67.2 ± 5.2                                              73.5 ± 10.3             71.7 ± 9.0
  HR (beats/min)                                   65.3 ± 10.8                     68.5 ± 8.4                                              83.3 ± 12.9             88.3 ± 8.8
  SpO~2~ (%)                                       98.0 (1.0)                      98.0 (1.0)                                              88.5 ± 2.6              87.2 ± 3.1
  **HEMATOLOGICAL PARAMETERS**                                                                                                                                     
  WBC (10^9^/L)                                    5.61 ± 1.18                     6.31 ± 1.74                                             **6.33** ± **1.09**     **7.22** ± **1.62**[^\*^](#TN1){ref-type="table-fn"}
  NEU[^\#^](#TN2){ref-type="table-fn"} (10^9^/L)   **2.94** ± **0.77**             **3.62** ± **1.35**[^\*^](#TN1){ref-type="table-fn"}    **3.26** ± **0.77**     **4.16** ± **1.31**^[^\#^](#TN2){ref-type="table-fn"}^
  LYM[^\#^](#TN2){ref-type="table-fn"} (10^9^/L)   2.23 ± 0.58                     2.27 ± 0.56                                             2.53 ± 0.43             2.30 (0.42)
  MON[^\#^](#TN2){ref-type="table-fn"} (10^9^/L)   0.25 (0.10)                     0.28 (0.10)                                             0.51 ± 0.14             0.53 ± 0.13
  EOS[^\#^](#TN2){ref-type="table-fn"} (10^9^/L)   0.10 (0.13)                     0.14 ± 0.09                                             0.11 (0.09)             0.15 ± 0.09
  NEU% (%)                                         52.13 ± 8.07                    56.09 ± 8.00                                            **51.04** ± **6.75**    **56.70** ± **6.59**^[^\#^](#TN2){ref-type="table-fn"}^
  LYM% (%)                                         40.03 ± 7.95                    36.75 ± 7.68                                            **37.70** ± **6.45**    **32.82** ± **6.13**[^\*^](#TN1){ref-type="table-fn"}
  MON% (%)                                         4.67 ± 1.07                     4.43 ± 1.01                                             8.10 ± 1.73             7.66 ± 1.14
  EOS% (%)                                         2.70 (2.30)                     2.70 (2.43)                                             1.90 (1.40)             2.07 ± 1.36
  RBC (10^12^/L)                                   4.94 (0.46)                     5.07 ± 0.37                                             5.41 (0.46)             5.51 ± 0.42
  HGB (g/L)                                        149.00 (11.00)                  150.09 ± 10.04                                          161.74 ± 11.04          165.95 ± 11.03
  HCT (%)                                          45.03 ± 3.24                    45.05 ± 3.05                                            48.09 ± 2.91            48.92 ± 2.91
  RET[^\#^](#TN2){ref-type="table-fn"} (10^9^/L)   **37.93** ± **12.25**           **45.41** ± **9.52**[^\*^](#TN1){ref-type="table-fn"}   No data                 
  RET% (%)                                         **0.76** ± **0.25**             **0.89 (0.22)**[^\*^](#TN1){ref-type="table-fn"}        No data                 

*HAH+, participants with high-altitude headache (HAH); HAH−, participants without HAH; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SpO~2~, pulse oxygen saturation*.

P-value is 0.05 or less;

*P-value is 0.01 or less; The bold data represent significant*.

HAH-related parameters at sea level
-----------------------------------

Compared to the HAH− group, the HAH+ group had significantly lower pre-exposure values for RET% (0.76 ± 0.25% vs. 0.89 ± 0.22%), RET\# (37.93 ± 12.25 10^9^/L vs. 45.41 ± 9.52 10^9^/L), and NEU\# (2.94 ± 0.77 10^9^/L vs. 3.62 ± 1.35 10^9^/L) (all *P* \< 0.05). There were no significant differences in the pre-exposure physiological parameters (all *P* \> 0.05, Table [1](#T1){ref-type="table"}, Supplementary Table [2A](#SM2){ref-type="supplementary-material"}).

HAH-related parameters at 3,700 m
---------------------------------

Compared to the HAH− group, the HAH+ group had significantly lower post-exposure values for NEU\# (51.04 ± 6.75 10^9^/L vs. 56.70 ± 6.59 10^9^/L), NEU% (3.26 ± 0.77% vs. 4.16 ± 1.31%), and WBC (6.33 ± 1.09 10^9^/L vs. 7.22 ± 1.62 10^9^/L), as well as significantly higher LYM% (37.70 ± 6.45% vs. 32.82 ± 6.13%) (all *P* \< 0.05). Similar to the pre-exposure, there were no significant differences in the post-exposure physiological parameters (all *P* \> 0.05, Table [1](#T1){ref-type="table"}, Supplementary Table [2A](#SM2){ref-type="supplementary-material"}).

Associations between HAH severity and the pre-/post-exposure parameters
-----------------------------------------------------------------------

Among the pre-exposure parameters, only RET\# was significantly associated with HAH severity (*r* = −0.315, *P* = 0.035). Among the post-exposure parameters, HAH severity was significantly and negatively associated with WBC (*r* = −0.319, *P* = 0.032), NEU\# (*r* = −0.315, *P* = 0.035), and NEU% (*r* = −0.383, *P* = 0.009). Furthermore, HAH severity was positively associated with post-exposure LYM% (*r* = 0.348, *P* = 0.019). No other significant associations were observed between the remaining demographic or physiological parameters and HAH severity (all *P* \> 0.05, Table [2](#T2){ref-type="table"}, Supplementary Table [2B](#SM2){ref-type="supplementary-material"}).

###### 

Relationships between HAH severity score and all the variables.

                                 **Variables at sea level**   **Variables at 3,700 m**                           
  ------------------------------ ---------------------------- -------------------------- ----------------------- ------------
  **DEMOGRAPHIC DATA**                                                                                           
  Age (year)                     0.276                        0.066                      The same as sea level   
  BMI (kg/m^2^)                  −0.017                       0.914                      The same as sea level   
  **PHYSIOLOGICAL PARAMETERS**                                                                                   
  SBP (mmHg)                     0.088                        0.565                      0.046                   0.764
  DBP (mmHg)                     0.000                        0.999                      0.125                   0.414
  HR (beat/min)                  −0.218                       0.150                      −0.278                  0.064
  SpO~2~ (%)                     −0.151                       0.323                      0.145                   0.341
  **HEMATOLOGICAL PARAMETERS**                                                                                   
  WBC (10^9^/L)                  −0.266                       0.078                      −**0.319**              \<**0.05**
  NEU\# (10^9^/L)                −0.260                       0.085                      −**0.383**              \<**0.01**
  LYM\# (10^9^/L)                −0.026                       0.866                      0.285                   0.058
  MON\# (10^9^/L)                −0.190                       0.210                      −0.113                  0.460
  EOS\# (10^9^/L)                −0.007                       0.966                      −0.038                  0.805
  NEU% (%)                       −0.238                       0.115                      −**0.437**              \<**0.01**
  LYM% (%)                       0.237                        0.117                      **0.348**               \<**0.05**
  MON% (%)                       0.123                        0.421                      0.168                   0.270
  EOS% (%)                       −0.055                       0.720                      0.040                   0.793
  RBC (10^12^/L)                 −0.115                       0.451                      −0.252                  0.096
  HGB (g/L)                      −0.066                       0.665                      −0.236                  0.119
  HCT (%)                        0.036                        0.813                      −0.218                  0.151
  RET\# (10^9^/L)                −**0.315**                   \<**0.05**                 No data                 
  RET% (%)                       −0.283                       0.059                      No data                 

*HAH, High-altitude headache; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SpO~2~, pulse oxygen saturation. The bold data represent significant*.

Predictors and risk factors for HAH
-----------------------------------

Among the pre-exposure parameters, the univariate logistic regression analyses revealed that only RET\# was significantly associated with HAH (*P* \< 0.05, Table [3](#T3){ref-type="table"}, Supplementary Table [2C](#SM2){ref-type="supplementary-material"}). Among the post-exposure parameters, the univariate analyses revealed that HAH was significantly associated with WBC, NEU\#, NEU%, and LYM% (all *P* \< 0.05, Table [4](#T4){ref-type="table"}, Supplementary Table [2C](#SM2){ref-type="supplementary-material"}). The adjusted logistic regression analyses revealed that HAH was independently predicted by pre-exposure low RET\#, and that low post-exposure NEU% was an independent risk factor for HAH (all *P* \< 0.05, Table [5](#T5){ref-type="table"}).

###### 

Univariate logistic regression for each variable at sea level.

                                                          **95% CI**               
  ------------------------------ ------------ ----------- ------------ ----------- ------------
  **DEMOGRAPHIC DATA**                                                             
  Age (year)                     0.208        1.231       0.965        1.572       0.095
  BMI (kg/m^2^)                  −0.506       0.603       0.091        4.008       0.601
  Smoking                        0.199        1.220       0.626        2.378       0.560
  Drinking                       −0.043       0.958       0.699        1.313       0.789
  **PHYSIOLOGICAL PARAMETERS**                                                     
  SBP (mmHg)                     0.008        1.008       0.931        1.092       0.845
  DBP (mmHg)                     −0.006       0.994       0.905        1.092       0.903
  HR (beat/min)                  −0.037       0.964       0.905        1.028       0.261
  SpO~2~ (%)                     −0.527       0.590       0.249        1.401       0.232
  **HEMATOLOGICAL PARAMETERS**                                                     
  WBC (10^9^/L)                  −0.376       0.687       0.415        1.136       0.143
  NEU\# (10^9^/L)                −0.679       0.507       0.252        1.023       0.058
  LYM\# (10^9^/L)                −0.126       0.882       0.310        2.505       0.813
  MON\# (10^9^/L)                −3.168       0.042       0.000        19.531      0.312
  EOS\# (10^9^/L)                1.173        3.233       0.044        237.534     0.593
  NEU% (%)                       −0.064       0.938       0.867        1.015       0.111
  LYM% (%)                       0.057        1.058       0.977        1.146       0.167
  MON% (%)                       −0.082       0.921       0.736        1.153       0.473
  EOS% (%)                       0.964        2.623       0.016        443.888     0.713
  RBC (10^12^/L)                 −0.572       0.565       0.190        1.679       0.304
  HGB (g/L)                      −0.022       0.979       0.922        1.039       0.478
  HCT (%)                        −0.003       0.997       0.825        1.206       0.975
  RET\# (10^9^/L)                −**0.065**   **0.937**   **0.882**    **0.996**   \<**0.05**
  RET% (%)                       −2.701       0.067       0.004        1.125       0.060

*CI, Confidence interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SpO~2~, pulse oxygen saturation. The bold data represent significant*.

###### 

Univariate logistic regression for each variable at 3,700 m.

                                                                          **95% CI**               
  ---------------------------------------------- ------------ ----------- ------------ ----------- ------------
  **DEMOGRAPHIC DATA (THE SAME AS SEA LEVEL)**                                                     
  **Physiological parameters**                                                                     
  SBP (mmHg)                                     −0.005       0.995       0.948        1.044       0.845
  DBP (mmHg)                                     0.021        1.021       0.959        1.086       0.518
  HR (beat/min)                                  −0.042       0.959       0.906        1.014       0.143
  SpO~2~ (%)                                     0.167        1.182       0.952        1.468       0.130
  **Hematological parameters**                                                                     
  WBC (10^9^/L)                                  −**0.579**   **0.561**   **0.315**    **0.996**   \<**0.05**
  NEU\# (10^9^/L)                                −**0.961**   **0.382**   **0.177**    **0.825**   \<**0.05**
  LYM\# (10^9^/L)                                1.038        2.823       0.642        12.417      0.170
  MON\# (10^9^/L)                                −1.445       0.236       0.002        22.793      0.536
  EOS\# (10^9^/L)                                0.737        2.089       0.017        252.777     0.763
  NEU% (%)                                       −**0.128**   **0.880**   **0.796**    **0.973**   \<**0.05**
  LYM% (%)                                       **0.126**    **1.134**   **1.020**    **1.261**   \<**0.05**
  MON% (%)                                       0.213        1.238       0.815        1.880       0.317
  EOS% (%)                                       0.102        1.107       0.798        1.536       0.543
  RBC (10^12^/L)                                 −0.907       0.404       0.096        1.697       0.216
  HGB (g/L)                                      −0.036       0.964       0.912        1.020       0.206
  HCT (%)                                        −0.103       0.902       0.730        1.114       0.338

*CI, Confidence interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SpO~2~, pulse oxygen saturation. The bold data represent significant*.

###### 

Adjusted logistic regression for HAH at sea level and 3,700 m.

                                                **95% CI**           
  ---------------------------- -------- ------- ------------ ------- ---------
  **VARIABLES AT SEA LEVEL**                                         
  RET\# (10^9^/L)              −0.065   0.937   0.882        0.996   \< 0.05
  **VARIABLES AT 3,700 M**                                           
  NEU% (%)                     −0.128   0.880   0.796        0.973   \<0.05

*CI, Confidence interval*.

Discussion {#s4}
==========

The present study revealed that some hematological parameters may be novel independent risk factors/predictors for HAH. For example, HAH was associated with low pre-exposure values for RET\#, RET%, and NEU\#. In addition, the HAH group had low post-exposure values for NEU\#, NEU%, and WBC, as well as high values for LYM%. Moreover, HAH was independently predicted by low pre-exposure RET\#, while low post-exposure NEU% was an independent risk factor for HAH.

HAH is associated with reticulocyte and neutrophil counts at sea level
----------------------------------------------------------------------

The present study revealed that low pre-exposure RET\# was associated with the development of HAH at an altitude of 3,700 m. Furthermore, the severity of HAH was negatively associated with RET\#. In this context, reticulocytes are immature RBCs and circulate in the bloodstream for approximately 1--4 days before developing into young mature RBCs (Lombardi et al., [@B30]). Interestingly, hypoxia stress can stimulate the production of reticulocytes (MacNutt et al., [@B32]), and young mature RBCs have greater affinity for oxygen plus more efficient oxygen delivery to the tissues, compared to old RBCs (Samaja et al., [@B39]; Cohen and Matot, [@B11]). Moreover, a recent open-label randomized controlled trial revealed that erythropoietin (which stimulates hematopoiesis) is an effective prophylaxis for AMS (Heo et al., [@B19]). Therefore, our results may support the prevention of HAH using prophylactic induction of hematopoiesis in case with anticipated acute exposure to a hypoxic environment.

Our results also indicate that the HAH+ group had significantly lower pre-exposure NEU\#, compared to the HAH− group. Previous studies have demonstrated that neutrophils undergo cellular adhesion and trans-endothelial migration from the blood stream during inflammation (Hall, [@B18]). In addition, hypobaric hypoxia could readily amplify pre-existing inflammation, which might lead to cerebral edema and AMS (Eltzschig and Carmeliet, [@B15]; Song et al., [@B42]). Furthermore, a recent study demonstrated that inflammation at sea level could predict the development of AMS (Lu et al., [@B31]). Thus, our results may indicate that inflammation at sea level is a risk factor for HAH.

Neutrophil recruitment during HAH
---------------------------------

Our results indicate that the HAH+ had significantly lower values for NEU\# and NEU%, and higher values for LYM%. Furthermore, HAH severity was negatively associated with NEU\# and NEU%, while HAH severity was positively associated with LYM%. Although the relevance of these findings is unclear, there are several potential explanations.

The first potential explanation is that neutrophils undergo trans-endothelial migration from the blood stream during inflammation, which is related to the similar mechanisms underlying stroke and AMS (Jin et al., [@B22]; Julian et al., [@B23]; Hall, [@B18]). Moreover, neutrophils are among the first cells to infiltrate the ischemic brain (within 30 min to a few hours after developing focal cerebral ischemia), where they amplify the inflammatory response with the help of cytokines (e.g., interleukin-1β \[IL-1β\], IL-6, and tumor necrosis factor-α \[TNF-α\]) that are produced by activated microglial cells (Ziemka-Nalecz et al., [@B44]). Intriguingly, our previous study revealed that plasma levels of IL-1β, IL-6, and TNF-α were positively correlated with AMS severity at 3,700 m, and another recent study revealed that plasma IL-6 levels were positively associated with AMS severity at 4,450 m and 5,129 m (Boos et al., [@B6]; Song et al., [@B42]). Thus, we speculate that hypobaric hypoxia induces brain injury by recruiting circulating neutrophils that aggravate neurogenic inflammation and lead to the development of HAH.

The second potential explanation is that neutrophil recruitment may be due to dampened anti-inflammatory IL-10 and upregulated C-C Motif Chemokine Ligand 8 (CCL8). For example, our recent transcriptome analysis revealed that IL-10 is downregulated in AMS, whereas CCL8 is upregulated (Liu et al., [@B28]). In addition, IL-10 is a general suppressor of the inflammatory response, while CCL8 promotes neutrophil recruitment (O\'Boyle et al., [@B35]; Ouyang et al., [@B36]). Thus, we speculate that the lower NEU\# and NEU% in patients with HAH are associated with the reduction of IL-10 and upregulation of CCL8, and this topic warrants urgent investigation. The third potential explanation is that the relatively high LYM% in patients with HAH could be the result of lower NEU%, as patients with and without HAH had similar values for LYM\#.

Independent predictors and risk factors for HAH
-----------------------------------------------

The adjusted logistic regression analyses revealed that low post-exposure NEU% was a risk factor for HAH. This may be because of the inflammatory response that is induced during HAH development. In addition, HAH was independently predicted by low RET\#. This may reflect an impaired ability to produce young mature RBCs, which would decrease oxygen delivery to the tissues at high altitudes.

Limitations
-----------

Ours is the first study to examine the hematological characteristics of HAH, and provides the first step toward linking the fields of hematology and HAH. However, the study also has several limitations. First, we only examined a small cohort of young Chinese men, which could have introduced age- or sex-related bias. Second, we did not have access to post-exposure reticulocyte data. Thus, our findings should be validated using larger and more heterogeneous cohorts, as well as more complete experimental data.

Conclusion {#s5}
==========

The present study is the first to examine the hematological characteristics of HAH, and revealed that HAH was closely associated with WBC, NEU\#, NEU%, LYM%, RET\#, and RET%. In addition, HAH was independently predicted by low pre-exposure RET\#, and low post-exposure NEU% was an independent risk factor for HAH.
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AMS

:   Acute mountain sickness

CCL8

:   C-C Motif Chemokine Ligand 8

CI

:   confidence interval

DBP

:   diastolic blood pressure

HAH

:   high-altitude headache

HAH+

:   participants with HAH

HAH−

:   participants without HAH

HR

:   heart rate

IL-1β

:   interleukin-1β

IL-6

:   interleukin-6

IL-10

:   interleukin-10

SBP

:   systolic blood pressure

SpO~2~

:   pulse oxygen saturation

TNF-α

:   tumor necrosis factor-α.
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